Consent to the Distribution of a New Medicine Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the Schedule hereto: Schedule Product: Fluohexal. Active Ingredient(s): Fluoxetine hydrochloride 22.4 mg equivalent to 20 mg fluoxetine. Dosage Form: Capsule. NZ Sponsor: Hexal New Zealand Limited. Manufacturer(s): Hexal-Pharma GmbH, Holzkirchen, Germany. Salutas Pharma GmbH, Barleben, Germany. Dated this 17th day of October 1999. S. S. JESSAMINE, Acting Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).